Mutation analysis and loss of heterozygosity of PEDF in central nervous system primitive neuroectodermal tumors

International Journal of Cancer

Volumn 72, Issue 2, 1997, Pages 277-282

  Slavc, Irene ^a   Rodriguez, Ignacio R ^b   Mazuruk, Krzysztof ^b   Chader, Gerald J ^b   Biegel, Jaclyn A ^c  

^a UNIVERSITY OF VIENNA   (Austria)

^b NATIONAL EYE INSTITUTE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE PROTEINASE INHIBITOR;

ADOLESCENT; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHROMOSOME 17P; CHROMOSOME MAP; CLINICAL ARTICLE; DELETION MUTANT; DNA POLYMORPHISM; DNA SEQUENCE; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KARYOTYPING; MALE; NEUROECTODERM TUMOR; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ALLELES; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; DNA MUTATIONAL ANALYSIS; EYE PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HUMANS; INFANT; MALE; MUTATION; NERVE GROWTH FACTORS; NEUROECTODERMAL TUMORS, PRIMITIVE; PROTEINS; SERPINS;

EID: 0030850085     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970717)72:2<277::AID-IJC13>3.0.CO;2-D     Document Type: Article

References (29)

1. BATRA, S.K., MCLENDON, R.E., KOO, J.S., CASTELINI-PRABHU, S., FUCHS, H.E., KRISCHER, J.P., FRIEDMAN, H.S., BIGNER, D.D. and BIGNER, S.H., Prognostic implications of chromosome 17p deletions in human medulloblastomas. J. Neurooncol., 24, 39-45 (1995).
2. BIEGEL, J.A., BURK, C.D., BARR, F.G. and EMANUEL, B.S., Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res., 52, 3391-3395 (1992).
3. BIEGEL, J.A., RORKE, L.B., JANSS, A.J., SUTTON, L.N. and PAMITER, A.H., Isochromosome 17q demonstrated by interphase fluorescence in situ hybridization in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer, 14, 85-96 (1995).
4. BIEGEL, J.A., RORKE, L.B., PACKER, R.J., SUTTON, L.N., SCHUT, L., BONNER, K. and EMANUEL, B.S., Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer, 1, 139-147 (1989).
5. CHUNG, R. and 12 OTHERS, TP53 gene mutations and 17p deletions in human astrocytomas. Genes Chromosomes Cancer, 3, 323-331 (1991).
6. COGEN, P.H., Prognostic significance in molecular genetic markers in childhood brain tumors. Pediatr. Neurosurg., 17, 245-250 (1991).
7. COLES, C., THOMPSON, A.M., ELDER, P.A., COHEN, B.B., MACKENZIE, I.M., CRANSTON, G., CHETTY, U., MACKAY, J., MACDONALD, M., NAKAMURA, Y., HOYHEIM, B. and STEEL, C.M., Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet, 336, 761-763 (1990).
8. CORNELIS, R.S., VAN VLIET, M., VOS, C.B., CLETON-JANSEN, A.M., VAN DE VIJVER, M.J., PETERSE, J.L., KHAN, P.M., BORRESEN, A.L., CORNELISSE, C.J. and DEVILEE, P., Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res., 54, 4200-4206 (1994).
9. FELIX, C.A., POPLACK, D.G., REAMAN, G.H., STEINBERG, S.M., COLE, D.E., TAYLOR, B.J., BEGLEY, C.G. and KIRSCH, I.R., Characterization of immunoglobulin and T-cell receptor gene pattern in B-cell precursor acute lymphoblastic leukemia of childhood. J. clin. Oncol., 8, 431-142 (1990).
10. FELIX, C.A., SLAVC, I., DUNN, M., STRAUSS, E.A., PHILLIPS, P.C., RORKE, L.B., SUTTON, L. and BIEGEL, J.A., Germline and somatic p53 gene mutations in pediatric brain tumors. Med. Pediatr. Oncol., 25, 431-436 (1995).
11. GURWITZ, D. and CUNNINGHAM, D.D., Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc. nat. Acad. Sci. (Wash.), 85, 3440-3444 (1988).
12. KLEIHUES, P., BURGER, O.C. and SCHEITHAUER, B.W. (Eds.) Histologic typing of tumours of the central nervous system, Springer, Berlin (1993).
13. MAKOS WALES, M., BIEL, M.A., DEIRY, W.E., NELKIN, B.D., ISSA, J.P., CAVENEE, W.K., KUERBITZ, S.J. and BAYLIN, S.B., p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature (Med.), 1, 570-577 (1995).
14. MCDONALD, J.D., DANESHVAR, L., WILLERT, J.R., MATSUMARA, K., WALDMAN, F. and COGEN, P.H., Physical mapping of chromosome 17p13.3 in the region of the putative tumor suppressor gene important in medulloblastoma. Genomics, 23, 229-232 (1994).
15. MOLENAAR, W.M., JANSSON, D.S., GOULD, V.E., RORKE, L.B., FRANKE, W.W., LEE, V.M.-Y., PACKER, R.J. and TROJANOWSKI, J.Q., Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Lab. Invest., 61, 635-643 (1989).
16. ORITA, M., IWAHARA, H., KANAZAWA, H., HAYASHI, K. and SEKIYA, T., Detection of polymorphisms of human DNA by gel electropheresis as single-strand conformation polymorphisms. Proc. nat. Acad. Sci. (Wash.), 86, 2766-2770 (1989).
17. ORITA, M.Y., SUZUKI, Y., SEKIYA, T. and HAYASHI, K., Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 8, 271-278 (1989).
18. RAFFEL, C., THOMAS, G.A., TISHLER, D.M., LASSOFF, S. and ALLEN, J.C., Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tumors. Neurosurgery, 33, 301-306 (1993).
19. SAYLORS, R.L., SIDRANSKY, D., FRIEDMAN, H.S., BIGNER, S.H., BIGNER, D.D., VOGELSTEIN, B. and BRODEUR, G.M., Infrequent p53 mutations in medulloblastomas. Cancer Res., 51, 4721-4723 (1991).
20. SHEFFIELD, V.C., BECK, J.S., KWITEK, A.E., SANDSTROM, D.W. and STONE, E.M., The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitution. Genomics, 16, 325-332 (1993).
21. STEELE, F.R., CHADER, J.G., JOHNSON, L.V. and TOMBRAN-TINK, J., Pigment epithelium-derived factor: Neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc. nat. Acad. Sci. (Wash.), 90, 1526-1530 (1992).
22. TANIWAKI, T., BECERRA, S.P., CHADER, G.J. and SCHWARTZ, J.P., Pigment epithelium-derived factor is a survival for cerebellar granule cells in culture. J. Neurochem., 64, 2509-2517 (1995).
23. TOMBRAN-TINK, J., CHADER, G.J. and JOHNSON, L.V., PEDF: a pigment epithelium derived-factor with potent neuronal differentiative activity. Exp. Eye Res., 53, 411-414 (1991).
24. TOMBRAN-TINK, J. and JOHNSON, L.V. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPR cells. Invest. Ophthalmol. Vis. Sci., 30, 1700-1707 (1989).
25. TOMBRAN-TINK, J., MAZURUK, K., RODRIGLIEZ, I., CHUNG, D., LINKEZ, T., ENGLANDER, E. and CHADER, G.J., Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol. Vision, 2, 11-22 (1996).
26. TOMBRAN-TINK, J., PAWAR, H., SWAROOP, A., RODRIGUEZ, I. and CHADER, G.J., Localization of the gene for pigment epithelium-derived factor to chromosome 17p13.1 and expression in cultured human retinoblastoma cells. Genomics, 19, 266-272 (1994).
27. TOMBRAN-TINK, J., SHIVARAM, S.M., CHADER, G.J., JOHNSON, L.V. and BOK, D., Expression, secretion, and age-related downregulation of pigment-epithelium derived factor, a serpin with neurotrophic activity. J. Neurosci., 15, 4992-5003 (1995).
28. ZOU, Z., ANISOWICZ, A., HENDRIX, M.J.C., THOR, A., NEVEU, M., SHENG, S., RAFIDI, K., SEFTOR, E. and SAGER, R., Maspin, a serpin with tumor-suppressor activity in human mammary epithelial cells. Science, 263, 526-529 (1994).
29. ZURN, A.D., NICK, H. and MONARD, D., A glia derived nexin promotes neurite outgrowth in cultured chick sympathetic neurons. Dev. Neurosci., 10, 17-24 (1988).